Novus Biologicals™ Recombinant Human 4-1BB/TNFRSF9/CD137 Protein

Catalog No.	Quantity
NB816366	1 mg
NB815916	500 μg
NB815760	5 μg
NB815679	100 μg

Catalog No. NB816366 Supplier Novus Biologicals™ Supplier No. NBP2349581MG

Description

Recombinant Protein

CD137 protein is fully biologically active when compared to standard. The biological activity is determined by its inhibitory effect of IL-8 production using human peripheral blood mononuclear cells. About 90 % of inibition was seen using a concentration of 1 μg for both 4-1BB Ligand and 4-1BB Receptor.

Specifications

• Accession Number: Q07011, Q07011, Q07011
• Concentration: LYOPH
• For Use With (Application): PAGE, Bioactivity
• Formulation: Lyophilized from a 0.2 um filtered concentrated solution in 10 mM PB, pH 8.0, 150 mM NaCl.
• Gene ID (Entrez): 3604
• Molecular Weight (g/mol): 17.7 kDa
• Quantity: 1 mg
• Storage Requirements: Store at -20°C to -70°C as supplied. After reconstitution, store at 2°C to 8°C for 1 month and at -20°C to -70°C for long term storage. Avoid repeated freeze-thaw cycles.
• Endotoxin Concentration: Less than 1 EU/ug of 4-1BB/TNFRSF9/CD137 as determined by LAL method.
• Gene Alias: 4-1BB, 4-1BB ligand receptor, CD137 antigen, CD137MGC2172, CDw137, FLJ43501, ILAhomolog of mouse 4-1BB, induced by lymphocyte activation (ILA), interleukin-activated receptor, homolog of mouse Ly63, receptor protein 4-1BB, T cell antigen ILA, T-cell antigen 4-1BB homolog, T-cell antigen ILA, tumor necrosis factor receptor superfamily member 9, tumor necrosis factor receptor superfamily, member 9
• Gene Symbol: TNFRSF9
• Reconstitution: Recommended to centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/mL. Apportion stock solutions into working aliquots and store at <-20°C.
• Research Category: Apoptosis, Cancer, Cell Biology, Immune System Diseases, Immunology, Stem Cells
• Purity or Quality Grade: >97% pure by SDS-PAGE and HPLC
• Protein: 4-1BB/TNFRSF9/CD137